Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice.
Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice.
复制标题
DOI:
10.4049/jimmunol.181.5.3202
复制
发表时间:
2008-09-01
期刊:
影响因子:
--
通讯作者:
Forsthuber TG
中科院分区:
文献类型:
--
作者:
Kawamura K;McLaughlin KA;Weissert R;Forsthuber TG
Genes of the major histocompatibility complex (MHC) show the strongest genetic association with multiple sclerosis (MS) but the underlying mechanisms have remained unresolved. Here, we asked whether the MS-associated MHC class II molecules, HLA-DRB1*1501, HLA-DRB5*0101, and HLA-DRB1*0401 contribute to autoimmune central nervous system (CNS) demyelination by promoting pathogenic T cell responses to human myelin basic protein (hMBP), using three transgenic (Tg) mouse lines expressing these MHC molecules. Unexpectedly, profound T cell tolerance to the high-affinity MHC-binding hMBP82-100 epitope was observed in all Tg mouse lines. T cell tolerance to hMBP82-100 was abolished upon backcrossing the HLA-DR Tg mice to MBP-deficient mice. In contrast, T cell tolerance was incomplete for low-affinity MHC-binding hMBP epitopes. Furthermore, hMBP82-100-specific “type B” T cells escaped tolerance in HLA-DRB5*0101 Tg mice. Importantly, T cells specific for low-affinity MHC-binding hMBP epitopes and hMBP82-100-specific “type B” T cells were highly encephalitogenic. Collectively, the results show that MS-associated MHC class II molecules are highly efficient at inducing T cell tolerance to high-affinity MHC-binding epitope, whereas autoreactive T cells specific for the low-affinity MHC-binding epitopes and “type B” T cells can escape the induction of T cell tolerance and may promote MS.
登录
查看更多内容
DOI:
10.1084/jem.183.6.2635
发表时间:
1996-06-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Ito K;Bian HJ;Molina M;Han J;Magram J;Saar E;Belunis C;Bolin DR;Arceo R;Campbell R;Falcioni F;Vidović D;Hammer J;Nagy ZA
通讯作者:
Nagy ZA
DOI:
10.1084/jem.193.1.1
发表时间:
2001-01-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Anderton SM;Radu CG;Lowrey PA;Ward ES;Wraith DC
通讯作者:
Wraith DC
影响因子:
4.4
作者:
Karulin, AY;Hesse, MD;Lehmann, PV
通讯作者:
Lehmann, PV
影响因子:
4.4
作者:
Lovitch, SB;Walters, JJ;Unanue, ER
通讯作者:
Unanue, ER
影响因子:
4.4
作者:
Bielekova, B;Sung, MH;Martin, R
通讯作者:
Martin, R